Vaccination halves risk of long Covid

Being vaccinated against Covid halves people's risk of developing long Covid, according to new research from the University of East Anglia. Long Covid still affects...

Further illnesses still expected from SARS-CoV-2

SARS-CoV-2: Only neutralising antibodies allow conclusions to be drawn about protection against new infections: Mutations of virus and illnesses caused by new variants are still to...

Smoking rates surge during COVID-19

Smoking rates surge during COVID-19: University of Queensland researchers have found nicotine consumption in Australia increased by 30 per cent during the early stages of...

First-line defences short-lived

First-line immune defences against COVID-19 are short-lived and may explain reinfection. A new study finds that antibodies produced in the nose decline nine months after...